CSIMarket Company Name, Ticker, Industry, else..


Boston Scientific Corporation  (NYSE: BSX)
Other Ticker:  
 

Boston Scientific Corporation

BSX's Fundamental analysis



Looking into Boston Scientific growth rates, revenue grew by 20.9 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 602

Medical Equipment & Supplies industry recorded deterioration of revenues by -0.36 %

Boston Scientific's net income grew by 36.31 % in first quarter of 2025 year on year, above company average,

• More on BSX's Growth


Boston Scientific
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Boston Scientific PEG ratio is at 4.09 Boston Scientific realized cash reduction of $ -1.06 per share in trailing twelve-month period.
Company
75.55
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 8.78.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.16.


• More on BSX's Valuation
 
 Total Debt (Millions $) 11,309
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 365,688
 Net Income/Employee (TTM) $ 42,188
 Receivable Turnover (TTM) 6.92
 Tangible Book Value (Per Share $) -0.98

Boston Scientific
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Boston Scientific PEG ratio is at 4.09 Boston Scientific realized cash outflow of $ -1.06per share in trailing twelve-month period.
Company
75.55
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 8.78.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.16.

Boston Scientific Price to Book Ratio is at 6.86 higher than Industry Avg. of -581.46, and higher than S&P 500 Avg. of 0.01

• More on BSX's Valuation

•  Market Capitalization (Millions $) 154,088
•  Shares Outstanding (Millions) 1,493
•  Employees 48,000
•  Revenues (TTM) (Millions $) 17,553
•  Net Income (TTM) (Millions $) 2,025
•  Cash Flow (TTM) (Millions $) -1,577
•  Capital Exp. (TTM) (Millions $) -798
•  Total Debt (Millions $) 11,309
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 365,688
•  Net Income/Employee(TTM) $ 42,188
•  Receivable Turnover Ratio (TTM) 6.92
•  Tangible Book Value (Per Share $) -0.98

•  Market Capitalization (Millions $) 154,088
•  Shares Outstanding (Millions) 1,493
•  Employees 48,000
•  Revenues (TTM) (Millions $) 17,553
•  Net Income (TTM) (Millions $) 2,025
•  Cash Flow (TTM) (Millions $) -1,577
•  Capital Exp. (TTM) (Millions $) -798


    BSX's Profitability Comparisons
Boston Scientific achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in first quarter of 2025 to 19.75 % from 14.8 % in IV. Quarter.

Boston Scientific net profit margin of 14.41 % is currently ranking no. 17 in Medical Equipment & Supplies industry, ranking no. 75 in Healthcare sector and number 945 in S&P 500.


Profitability by Segment
Total 14.41 %



  Ratio
•   Capital Ratio (MRQ) 1.45
•  Total Debt to Equity (MRQ) 0.5
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.5
•  Inventory Turnover Ratio (TTM) 1.99



Boston Scientific achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in first quarter of 2025 to 19.75 % from 14.8 % in IV. Quarter.

Boston Scientific net profit margin of 14.41 % is currently ranking no. 17 in Medical Equipment & Supplies industry, ranking no. 75 in Healthcare sector and number 945 in S&P 500.

• More on BSX's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com